Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.

Kaye DM, Silvestry FE, Gustafsson F, Cleland JG, van Veldhuisen DJ, Ponikowski P, Komtebedde J, Nanayakkara S, Burkhoff D, Shah SJ.

Eur J Heart Fail. 2017 Dec;19(12):1690-1697. doi: 10.1002/ejhf.930. Epub 2017 Oct 11.

PMID:
29024227
2.

One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.

Kaye DM, Hasenfuß G, Neuzil P, Post MC, Doughty R, Trochu JN, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Walton A, Muller D, Walters D, Hausleiter J, Raake P, Petrie MC, Bergmann M, Jondeau G, Feldman T, Veldhuisen DJ, Ponikowski P, Silvestry FE, Burkhoff D, Hayward C.

Circ Heart Fail. 2016 Dec;9(12). pii: e003662.

3.

Mechanistic insights into mitral regurgitation due to atrial fibrillation: "Atrial functional mitral regurgitation".

Liang JJ, Silvestry FE.

Trends Cardiovasc Med. 2016 Nov;26(8):681-689. doi: 10.1016/j.tcm.2016.04.012. Epub 2016 May 2. Review.

PMID:
27345155
4.

New Ventricular Septal Defects Following Balloon-Expandable Transcatheter Aortic Valve Replacement.

Rene AG, Jagasia D, Wickramasinghe SR, Desai N, Szeto W, Vallabhajosyula P, Li RH, Silvestry FE, Giri J, Jha S, Herrmann HC, Anwaruddin S.

J Invasive Cardiol. 2016 Jul;28(7):E59-65.

5.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).

Feldman T, Komtebedde J, Burkhoff D, Massaro J, Maurer MS, Leon MB, Kaye D, Silvestry FE, Cleland JG, Kitzman D, Kubo SH, Van Veldhuisen DJ, Kleber F, Trochu JN, Auricchio A, Gustafsson F, Hasenfuβ G, Ponikowski P, Filippatos G, Mauri L, Shah SJ.

Circ Heart Fail. 2016 Jul;9(7). pii: e003025. doi: 10.1161/CIRCHEARTFAILURE.116.003025.

6.

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.

Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM; REDUCE LAP-HF study investigators.

Lancet. 2016 Mar 26;387(10025):1298-304. doi: 10.1016/S0140-6736(16)00704-2.

PMID:
27025436
7.

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L; EVEREST II Investigators.

J Am Coll Cardiol. 2015 Dec 29;66(25):2844-2854. doi: 10.1016/j.jacc.2015.10.018.

8.

Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions.

Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y; American Society of Echocardiography; Society for Cardiac Angiography and Interventions.

J Am Soc Echocardiogr. 2015 Aug;28(8):910-58. doi: 10.1016/j.echo.2015.05.015. No abstract available.

PMID:
26239900
10.

Coronary sinus atrial communication in a 58 year old.

Kiss D, Lilly SM, Silvestry F.

Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1100. doi: 10.1093/ehjci/jeu100. Epub 2014 May 27. No abstract available.

PMID:
24866897
11.

Intracardiac echocardiography-guided transcatheter aortic valve replacement.

Kadakia MB, Silvestry FE, Herrmann HC.

Catheter Cardiovasc Interv. 2015 Feb 15;85(3):497-501. doi: 10.1002/ccd.25409. Epub 2014 Feb 10.

PMID:
24478152
12.

How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient?

Lilly SM, Rome J, Anwaruddin S, Shreenivas S, Desai N, Silvestry FE, Herrmann HC, Fassa A, Himbert D, Brochet E, Labbé JP, Depoix JP, Hvass U, Vahanian A, Holoshitz N, Kenny D, Hijazi ZM.

EuroIntervention. 2013 Jul;9(3):407-9. doi: 10.4244/EIJV9I3A64.

13.

4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation.

Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T; EVEREST II Investigators.

J Am Coll Cardiol. 2013 Jul 23;62(4):317-28. doi: 10.1016/j.jacc.2013.04.030. Epub 2013 May 9.

14.

Left ventricular remodeling in human heart failure: quantitative echocardiographic assessment of 1,794 patients.

Ky B, Plappert T, Kirkpatrick J, Silvestry FE, Ferrari VA, Keane MG, Wiegers SE, Chirinos JA, St John Sutton M.

Echocardiography. 2012 Aug;29(7):758-65. doi: 10.1111/j.1540-8175.2012.01701.x. Epub 2012 Apr 13.

PMID:
22497559
15.

Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial.

Herrmann HC, Gertz ZM, Silvestry FE, Wiegers SE, Woo YJ, Hermiller J, Segar D, Heimansohn D, Gray W, Homma S, Argenziano M, Wang A, Jollis J, Lampert MB, Alexander J, Mauri L, Foster E, Glower D, Feldman T.

J Am Coll Cardiol. 2012 Apr 3;59(14):1312-9. doi: 10.1016/j.jacc.2011.12.023.

16.

Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control.

Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE.

J Am Coll Cardiol. 2011 Sep 27;58(14):1474-81. doi: 10.1016/j.jacc.2011.06.032.

17.

EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.

Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD.

Eur Heart J. 2011 Sep;32(17):2189-214. doi: 10.1093/eurheartj/ehr259.

PMID:
21885465
18.

EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.

Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD.

J Am Soc Echocardiogr. 2011 Sep;24(9):937-65. doi: 10.1016/j.echo.2011.07.003. Review.

PMID:
21867869
19.

EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.

Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD, Vahanian A, Di Bello V, Buck T; Document Reviewers: European Association of Echocardiography (EAE): American Society of Echocardiography (ASE): The ASE Guidelines and Standards Committee and the ASE Board of Directors.

Eur J Echocardiogr. 2011 Aug;12(8):557-84. doi: 10.1093/ejechocard/jer086.

PMID:
21841044
20.

A 10-Fr ultrasound catheter with integrated micromotor for 4-D intracardiac echocardiography.

Lee W, Griffin W, Wildes D, Buckley D, Topka T, Chodakauskas T, Langer M, Calisti S, Bergstøl S, Malacrida JP, Lanteri F, Maffre J, McDaniel B, Shivkumar K, Cummings J, Callans D, Silvestry F, Packer D.

IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Jul;58(7):1478-91. doi: 10.1109/TUFFC.2011.1967.

PMID:
21768032

Supplemental Content

Loading ...
Support Center